263 related articles for article (PubMed ID: 20587403)
1. Novel treatment approaches for triple-negative breast cancer.
Telli ML; Ford JM
Clin Breast Cancer; 2010; 10 Suppl 1():E16-22. PubMed ID: 20587403
[TBL] [Abstract][Full Text] [Related]
2. The triple-negative subtype: new ideas for the poorest prognosis breast cancer.
Curigliano G; Goldhirsch A
J Natl Cancer Inst Monogr; 2011; 2011(43):108-10. PubMed ID: 22043054
[TBL] [Abstract][Full Text] [Related]
3. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancer.
Bartsch R; Ziebermayr R; Zielinski CC; Steger GG
Wien Med Wochenschr; 2010 Apr; 160(7-8):174-81. PubMed ID: 20473728
[TBL] [Abstract][Full Text] [Related]
5. "Targeting" triple-negative breast cancer: the lessons learned from BRCA1-associated breast cancers.
Nanda R
Semin Oncol; 2011 Apr; 38(2):254-62. PubMed ID: 21421115
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for triple-negative breast cancers with defective homologous recombination.
Jaspers JE; Rottenberg S; Jonkers J
Biochim Biophys Acta; 2009 Dec; 1796(2):266-80. PubMed ID: 19616605
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer: advancements in characterization and treatment approach.
Hurvitz S; Mead M
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):59-69. PubMed ID: 26694831
[TBL] [Abstract][Full Text] [Related]
8. Triple-negative breast cancer and poly(ADP-ribose) polymerase inhibitors.
Park Y; Moriyama A; Kitahara T; Yoshida Y; Urita T; Kato R
Anticancer Agents Med Chem; 2012 Jul; 12(6):672-7. PubMed ID: 22263793
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of triple-negative breast cancer.
de Ruijter TC; Veeck J; de Hoon JP; van Engeland M; Tjan-Heijnen VC
J Cancer Res Clin Oncol; 2011 Feb; 137(2):183-92. PubMed ID: 21069385
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy for triple-negative breast cancer: where are we?
Duffy MJ; McGowan PM; Crown J
Int J Cancer; 2012 Dec; 131(11):2471-7. PubMed ID: 22581656
[TBL] [Abstract][Full Text] [Related]
11. Triple-negative breast cancer: disease entity or title of convenience?
Carey L; Winer E; Viale G; Cameron D; Gianni L
Nat Rev Clin Oncol; 2010 Dec; 7(12):683-92. PubMed ID: 20877296
[TBL] [Abstract][Full Text] [Related]
12. Directed therapy of subtypes of triple-negative breast cancer.
Carey LA
Oncologist; 2011; 16 Suppl 1():71-8. PubMed ID: 21278443
[TBL] [Abstract][Full Text] [Related]
13. Directed therapy of subtypes of triple-negative breast cancer.
Carey LA
Oncologist; 2010; 15 Suppl 5():49-56. PubMed ID: 21138955
[TBL] [Abstract][Full Text] [Related]
14. Molecular stratification of triple-negative breast cancers.
Perou CM
Oncologist; 2010; 15 Suppl 5():39-48. PubMed ID: 21138954
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the heterogeneity of triple-negative breast cancer.
Metzger-Filho O; Tutt A; de Azambuja E; Saini KS; Viale G; Loi S; Bradbury I; Bliss JM; Azim HA; Ellis P; Di Leo A; Baselga J; Sotiriou C; Piccart-Gebhart M
J Clin Oncol; 2012 May; 30(15):1879-87. PubMed ID: 22454417
[TBL] [Abstract][Full Text] [Related]
16. [PARP inhibitors and their role in the therapy of triple-negative metastatic breast cancer].
Kozioł M; Püsküllüoglu M; Zygulska A
Przegl Lek; 2012; 69(6):265-70. PubMed ID: 23094440
[TBL] [Abstract][Full Text] [Related]
17. Molecular stratification of triple-negative breast cancers.
Perou CM
Oncologist; 2011; 16 Suppl 1():61-70. PubMed ID: 21278442
[TBL] [Abstract][Full Text] [Related]
18. The emerging potential of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.
Drew Y; Plummer R
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):67-71. PubMed ID: 19934756
[TBL] [Abstract][Full Text] [Related]
19. Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition.
Shibata H; Miuma S; Saldivar JC; Huebner K
Cancer Sci; 2011 Oct; 102(10):1882-8. PubMed ID: 21707865
[TBL] [Abstract][Full Text] [Related]
20. Triple negative breast cancer: a brief review of its characteristics and treatment options.
Griffiths CL; Olin JL
J Pharm Pract; 2012 Jun; 25(3):319-23. PubMed ID: 22551559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]